References 8164 Waterhouse L, London E, Gillberg C (2017). The ASD diagnosis has blocked
the discovery of valid biological variation in neurodevelopmental social
impairment. Autism Res., 10 (7):1182.
65 Keightley PD (2012). Rates and fitness consequences of new mutations in
humans. Genetics, 190 (2):295–304.
66 Jobling MA, Tyler‐Smith C (2017). Human Y‐chromosome variation in the
genome‐sequencing era. Nat. Rev. Genet., 18 (8):485–97.
67 Callaway E (2015). Genghis Khan’s genetic legacy has competition. The
Mongolian leader left a strong footprint in the Y chromosomes of modern
descendants — but he was not the only one. Nature, January 23, 2015. https://
http://www.nature.com/news/genghis‐khan‐s‐genetic‐legacy‐has‐competition‐1.
16767#auth‐1. Accessed July 18, 2015.
68 Kondrashov AS (2003). Direct estimates of human per nucleotide mutation
rates at 20 loci causing Mendelian diseases. Hum. Mutat., 21 (1):12–27.
69 Lynch M, Conery JS (2000). The evolutionary fate and consequences of
duplicate genes. Science, 290 (5494):1151–5.
70 Ossowski S, Schneeberger K, Lucas‐Lledó JI, et al. (2010). The rate and
molecular spectrum of spontaneous mutations in Arabidopsis thaliana.
Science, 327 (5961):92–4.
71 Mayer JD, Salovey P, Caruso DR (2008). Emotional intelligence: new ability or
eclectic traits? Am. Psychol., 63 (6):503–17.
72 Environmental Working Group (2007). FDA Warns Cosmetics Industry to
Follow Law on Untested Ingredients. http://www.ewg.org/news/testimony‐
official‐correspondence/fda‐warns‐cosmetics‐industry‐follow‐law‐untested‐
ingredients#.WekHZ1tSzb0. Accessed October 10, 2017.
73 Gore AC, Chappell VA, Fenton SE, et al. (2015). Executive Summary to
EDC‐2: The Endocrine Society’s Second Scientific Statement on Endocrine‐
Disrupting Chemicals. Endocr. Rev., 36 (6):593–602.